Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
AMYLYX PHARMACEUTICALS INC
Ticker: AMLX
CUSIP: 03237H101
Class: Common Stock
SummitTX Capital, L.P.'s Holding History (CIK: 0002052310)
Note: Option positions (PUT/CALL) are excluded.
Q4 2025
Shares
218,399
Value ($000)
$2,638
Avg Close
$13.58
Range
$11.69 - $16.96
Q3 2025
Shares
168,000
Value ($000)
$2,283
Avg Close
$9.41
Range
$5.97 - $15.14
Period
Shares
Value ($000)
Average Close
Price Range
Q4 2025
218,399
$2,638
$13.58
$11.69 - $16.96
Q3 2025
168,000
$2,283
$9.41
$5.97 - $15.14